Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today that it will highlight its EVIS X1™ endoscopy system and colorectal cancer screening solutions.
Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced that it will highlight its algorithm-powered emphysema screening program along with two exciting bronchoscopes compatible with the EVIS X1™ endoscopy system as part of the Olympus Hybrid Bronchoscopy.
NEO Semiconductor, a leading developer of innovative technologies for 3D NAND flash and DRAM memory, announced a performance boosting Floating Body Cell Mechanism for 3D X-DRAM. Andy Hsu, Founder & CEO presented groundbreaking Technology CAD (TCAD) simulation results for NEO's 3D X-DRAM™.
Olympus, a global medical technology company, announced two bronchoscopes as part of the EVIS X1 Endoscopy System. The EVIS X1 Endoscopy System represents the latest in diagnostic and therapeutic bronchoscopy from Olympus.
The U.S. Department of Health and Human Services (HHS) Office on Women's Health has announced that the Preeclampsia Foundation Cuff Kit™ program will be joining 10 other final phase winners for the HHS Hypertension Innovator Award Competition.
Lumenis Be Ltd., a leading energy-based medical device company for aesthetic and eye care applications, announced that triLift is the winner of the highly competitive "Best New Dermatology Technology Solution" award in the 8th annual MedTech Breakthrough Awards program.
CIONIC, the neurotech inventor of FDA-cleared bionic clothing to improve walking, strength, and overall mobility, announced significant updates to the Cionic Neural Sleeve experience in its latest software release.
Baptist Health and Caregility are pleased to announce an expanded partnership aimed at enhancing patient care across the Arkansas-based healthcare organization.
iHealth Labs, Inc. a leading provider of digital health solutions, announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company's 3-in-1 COVID-19/Flu A&B Rapid Test Kit.
Lucem Health™, a leader in AI-driven early disease detection solutions, announced the introduction of Reveal for Lung Cancer. This innovative new solution aims to help healthcare organizations improve the identification and engagement of patients at a higher statistical risk for certain respiratory illnesses, including cancers of the lung or trachea, facilitating earlier diagnosis and treatment.